Post Feed

Prescribers invited to shape Active Ingredient Prescribing Program

09 Nov 2023

The Department of Health and Aged Care is seeking prescriber and other stakeholder feedback about the use of the List of Medicines for Brand Consideration (LMBC) as a support tool to prescribing by brand name in addition to active ingredient, under the Active Ingredient Prescribing (AIP) Program.

The survey is open until 13 November 2023 by clicking the following link: https://consultations.health.gov.au/technology-assessment-access-division/consultation-on-the-active-ingredient-prescribing

Questions about the survey (or the AIP program) can be directed to AIPrescribing@health.gov.au .

http://www.health.gov.au/our-work/active-ingredient-prescribing